On December 1, 1998, Hoechst and Rhône-Poulenc announced the merger of their life sciences business to create Aventis. This new company would be the global leader in both the pharma and agro industries. The two companies had planned to take a phased approach in implementing the merger, over several years. However, resistance from Hoechst’s largest shareholder (Kuwait Petroleum Corporation) to this phased approach led the merger being considerably accelerated and completed in just one year. Aventis managed the challenges associated with integrating this “merger of equals” by focusing on manufacturing rationalization, information management and cultural integration.
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications